RNA-based aptamer technology is a new approach to make safer drugs, and allows for the creation of the drug along with the antidote at the same time. In this article, blood thinning agents are used as an example. Blood thinning agents are one of the most difficult classes of drugs to coordinate...
The Medical Quack .... by Barbara Duck
The Medical Quack
Sun, Oct 4 2009
Filed under: Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, Proteins, Pharma, Biotech, clinical trials, warfarin, Pharmacogenomics, Research and Development, molecular drug data, The Watchman, Aptamer, nucleic acid